{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The protein is believed to play a central role in the pathogenesis of Parkinson's disease (PD), as evidenced by the identification of single point mutations and gene duplication/triplication that are causally linked to early-onset familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the A30P variant, as it is associated with early-onset familial PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We probed the effects of a few key mutations on the coupled binding and folding of a-synuclein by using a combination of single-molecule (smFRET) and ensemble (far-UV CD) measurements.",
          "judgment": "Yes",
          "reasoning": "The general class of assays used, smFRET and far-UV CD, effectively model or reflect the disease pathogenesis/mechanism defined in Step 1, as they are used to study the binding and folding properties of a-synuclein variants.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Our results show that the A53T, E46K, and C-terminal-truncation mutations do not lead to loss of the multistate folding character of the WT protein. In contrast, the A30P mutation energetically favors population of the bent helix conformation.",
          "judgment": "Yes",
          "reasoning": "The specific instance of the assay was used to evaluate the effects of the A30P mutation on the folding and binding properties of a-synuclein, and the results were consistent with the expected outcomes for the variant.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The data presented herein demonstrate that in contrast with the other mutations studied, the A30P mutation significantly perturbs the binding–folding thermodynamics of a-synuclein and causes the protein to inherently favor the “I-state” bent helical structure over the “F-state” extended helix structure.",
          "judgment": "Yes",
          "reasoning": "The functional evidence from the assay is directly applied to the interpretation of the A30P variant, showing a significant perturbation in the binding-folding thermodynamics of a-synuclein.",
          "next_step_or_outcome": "PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The A30P mutation in a-synuclein significantly perturbs the binding-folding thermodynamics of the protein, causing it to favor the 'I-state' bent helical structure over the 'F-state' extended helix structure. This clear molecular consequence of a PD-related mutation provides very strong evidence for the pathogenicity of the A30P variant."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The protein is believed to play a central role in the pathogenesis of Parkinson's disease (PD), as evidenced by the identification of single point mutations and gene duplication/triplication that are causally linked to early-onset familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the A53T variant, as it is associated with early-onset familial PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We probed the effects of a few key mutations on the coupled binding and folding of a-synuclein by using a combination of single-molecule (smFRET) and ensemble (far-UV CD) measurements.",
          "judgment": "Yes",
          "reasoning": "The general class of assays used, smFRET and far-UV CD, effectively model or reflect the disease pathogenesis/mechanism defined in Step 1, as they are used to study the binding and folding properties of a-synuclein variants.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Our results show that the A53T, E46K, and C-terminal-truncation mutations do not lead to loss of the multistate folding character of the WT protein.",
          "judgment": "Yes",
          "reasoning": "The specific instance of the assay was used to evaluate the effects of the A53T mutation on the folding and binding properties of a-synuclein, and the results were consistent with the expected outcomes for the variant.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "At an SDS concentration of 1 mm, the A53T and E46K mutants maintained the three-state thermal-unfolding behavior exhibited by WT a-synuclein and populated the F conformational state in the temperature range investigated.",
          "judgment": "Yes",
          "reasoning": "The functional evidence from the assay is directly applied to the interpretation of the A53T variant, showing that it maintains the multistate folding character of the WT protein.",
          "next_step_or_outcome": "PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A53T mutation in a-synuclein does not lead to loss of the multistate folding character of the WT protein, maintaining the three-state thermal-unfolding behavior exhibited by WT a-synuclein. This provides supporting evidence for the pathogenicity of the A53T variant."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The protein is believed to play a central role in the pathogenesis of Parkinson's disease (PD), as evidenced by the identification of single point mutations and gene duplication/triplication that are causally linked to early-onset familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the E46K variant, as it is associated with early-onset familial PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We probed the effects of a few key mutations on the coupled binding and folding of a-synuclein by using a combination of single-molecule (smFRET) and ensemble (far-UV CD) measurements.",
          "judgment": "Yes",
          "reasoning": "The general class of assays used, smFRET and far-UV CD, effectively model or reflect the disease pathogenesis/mechanism defined in Step 1, as they are used to study the binding and folding properties of a-synuclein variants.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Our results show that the A53T, E46K, and C-terminal-truncation mutations do not lead to loss of the multistate folding character of the WT protein.",
          "judgment": "Yes",
          "reasoning": "The specific instance of the assay was used to evaluate the effects of the E46K mutation on the folding and binding properties of a-synuclein, and the results were consistent with the expected outcomes for the variant.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "At an SDS concentration of 1 mm, the A53T and E46K mutants maintained the three-state thermal-unfolding behavior exhibited by WT a-synuclein and populated the F conformational state in the temperature range investigated.",
          "judgment": "Yes",
          "reasoning": "The functional evidence from the assay is directly applied to the interpretation of the E46K variant, showing that it maintains the multistate folding character of the WT protein.",
          "next_step_or_outcome": "PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The E46K mutation in a-synuclein does not lead to loss of the multistate folding character of the WT protein, maintaining the three-state thermal-unfolding behavior exhibited by WT a-synuclein. This provides supporting evidence for the pathogenicity of the E46K variant."
    }
  ]
}